2019-11-25
Legal Press releases
Intervacc has, together with 3P Biopharmaceuticals and LIOF-Pharma (previously Praxis Pharmaceuticals), completed the manufacturing process for Strangvac®. The validation production batches required ... Read more
2019-11-12
Legal Press releases
Intervacc will shortly apply to the European Medicines Agency (EMA) to submit the company's registration application for Strangvac's approval during the first quarter of 2020.
The company has today decided to ... Read more
2019-09-11
Legal Press releases
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, HONG KONG, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION, ... Read more
2019-08-28
Legal Press releases
The animal health company Intervacc has through the wholly owned subsidiary Nordvacc Läkemedel AB (Nordvacc) expanded the distribution agreement with Ecuphar NV, a wholly owned subsidiary of Animalcare Group plc, a ... Read more
2019-08-07
Legal Press releases
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, finalized the production of the drug substances on a commercial scale in compliance with GMP (Good ... Read more
2019-06-11
Legal Press releases